Beone Medicines Ltd. Class A · SSE:688235
Brandicourt Olivier received 18,980 Beone Medicines Ltd. Class A shares as an award (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Brandicourt Olivier (Director) received 18,980 Beone Medicines Ltd. Class A shares as an award, leaving 46,306 shares. Filed Jun 15, 2026 (Form 4).
- Awarded
- 18,980 shares
- Holding after
- 46,306 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Ordinary Shares | Award | 18,980 | 46,306 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Brandicourt Olivier
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026